Discontinued — last reported Q1 '18
Corvex Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value increased by 506.8% to $10.71 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 506.8%, from $1.76 to $10.71.
Higher values suggest more generous equity compensation packages or higher stock price expectations at the time of grant.
The weighted average fair value at the grant date for equity instruments, excluding options, awarded to employees during...
Standard disclosure in stock-based compensation footnotes for most public companies.
other_share_based_compensation_arrangement_by_share_base_29f1a5| Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|
| Value | $1.77 | $1.77 | $1.77 | $1.77 | $10.71 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +506.8% |
| YoY Change | — | — | — | — | +506.8% |